Researchers discovered immune cell aggregates in the gut may signal blood vessel cells and fibroblasts to produce excess ...

Forlong Biotechnology, a clinical-stage biotech company focusing on developing transformative cytokine therapies for patients with severe unmet needs, today announced that preclinical data from its IL ...

In a single experiment, scientists can decipher the entire genomes of many patient samples, animal models, or cultured cells.

An innovative platform developed by PKU researchers called "cf-EpiTracing" has proved capable of detecting and tracing ...

Trenchant BioSystems and Invetech agreed to collaborate on the continued development of Trenchant’s fully automated AutoCell Platform, intended for future commercialization. According to company ...

Nanobodies—miniature proteins—derived from camel antibodies demonstrated powerful potential to accurately and safely deliver ...